Similar articles

• Dextrothyroxine therapy for the disordered lipid metabolism of preclinical hypothyroidism.

  Calay R, Kocheleff P, Jonniaux G, Sohet L, Bastenie PA. Calay R, et al. Lancet. 1971 Jan 30;1(7692):205-6. doi: 10.1016/s0140-6736(71)90948-2. Lancet. 1971. PMID: 4099873 Clinical Trial. No abstract available.
• Symptomatic atherosclerosis: prevention or modification by treatment with desiccated thyroid.

  Wren JC. Wren JC. J Am Geriatr Soc. 1971 Jan;19(1):7-22. doi: 10.1111/j.1532-5415.1971.tb01550.x. J Am Geriatr Soc. 1971. PMID: 5539637 No abstract available.
• Sudden coronary death: the Framingham Study.

  Kannel WB, Thomas HE Jr. Kannel WB, et al. Ann N Y Acad Sci. 1982;382:3-21. doi: 10.1111/j.1749-6632.1982.tb55203.x. Ann N Y Acad Sci. 1982. PMID: 7044245 Review. No abstract available.
• Coronary-artery disease in hypothyroidism.

  Bastenie PA, Vanhaelst L, Neve P. Bastenie PA, et al. Lancet. 1967 Dec 9;2(7528):1221-2. doi: 10.1016/s0140-6736(67)90562-4. Lancet. 1967. PMID: 4168694 No abstract available.
• Atherosclerosis in new world monkeys.

  Clarkson TB, Lehner ND, Bullock BC, Lofland HB, Wagner WD. Clarkson TB, et al. Primates Med. 1976;9:90-144. Primates Med. 1976. PMID: 813212 Review. No abstract available.